Pneumococcal conjugate second or third-dose vaccines (PCVc) in Laos
Laos: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 62.0% in 2025. ◆ Volatile
Latest (2025)
62.0%
Change on year
down 1.6%
World rank
144th
of 194 countries
All-time high
78.0%
in 2016
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Laos, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Laos recorded 62.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) in 2025.
The figure is down 1.6% on the previous year and down 12.7% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Laos peaked at 78.0% in 2016 and was at its lowest, 0.0%, in 2008.
That places Laos 144th out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Laos, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 68.0% | — |
| 2015 | 71.0% | +4.4% |
| 2016 | 78.0% | +9.9% |
| 2017 | 76.0% | -2.6% |
| 2018 | 74.0% | -2.6% |
| 2019 | 62.0% | -16.2% |
| 2020 | 58.0% | -6.5% |
| 2021 | 60.0% | +3.4% |
| 2022 | 64.0% | +6.7% |
| 2023 | 67.0% | +4.7% |
| 2024 | 63.0% | -6.0% |
| 2025 | 62.0% | -1.6% |
Laos compared with similar countries
- Laos's 62.0% is below the median for lower middle income countries, which is 84.0%, 74% of the median. (47 countries reporting)
- Laos's 62.0% is below the median for East Asia & Pacific, which is 81.0%, 77% of the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 42.9% | 0.0% | 78.0% | 10 |
| 2020s | 62.3% | 58.0% | 67.0% | 6 |
Countries ranked near Laos
- 141 Benin 64.0% compare
- 142 Democratic Republic of Congo 63.0% compare
- 142 Afghanistan 63.0% compare
- 144 Marshall Islands 62.0% compare
- 144 Nigeria 62.0% compare
- 147 North Macedonia 60.0% compare
More health data for Laos
- Un projection of annual infant deaths, annual growth rate -2.76 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5667 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,260 deaths per 1,000 people (2090)
- Number of infants who die before age 1 317 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 15 (2025)
- Population ages 00-04, female, annual growth rate -0.5161 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0489 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5055 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Laos?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Laos was 62.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Laos?
- The highest recorded value was 78.0% in 2016.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Laos?
- The lowest recorded value was 0.0% in 2008.
- How does Laos rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Laos ranks 144th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Laos?
- Over the last ten years it is down 12.7%. The long-run trend across the full record is volatile.
- Where does this Laos data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).